Diffuse large B-cell lymphoma (DLBCL) is a type of non-Hodgkin lymphoma characterized by the rapid proliferation of large B-cells. When it affects the intrathoracic lymph nodes, it can lead to significant clinical manifestations, including respiratory distress and systemic symptoms. Accurate coding with ICD-10 Code C83.32 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this aggressive malignancy.
What is ICD-10 Code C83.32 for Diffuse large B-cell lymphoma, intrathoracic lymph nodes?
ICD-10 Code C83.32 specifically denotes Diffuse large B-cell lymphoma affecting the intrathoracic lymph nodes. This aggressive form of lymphoma can lead to significant morbidity and requires prompt diagnosis and treatment. The code should be utilized in clinical documentation and billing when a patient presents with symptoms indicative of DLBCL localized to the thoracic lymphatic structures.
ICD-10 Code C83.32 – Clinical Definition and Explanation of Diffuse large B-cell lymphoma, intrathoracic lymph nodes
Diffuse large B-cell lymphoma is a hematological malignancy that arises from B-lymphocytes and can manifest in various lymphatic regions, including the intrathoracic lymph nodes. The condition is often aggressive and can lead to significant complications if not treated promptly. Medical attention is crucial for diagnosis and management.
Key Clinical Features:
- Rapidly enlarging lymph nodes in the thoracic region.
- Symptoms may include fever, night sweats, and weight loss.
- Possible respiratory symptoms due to lymph node compression.
- Diagnosis typically confirmed through biopsy and imaging studies.
ICD-10 Code C83.32 for Diffuse large B-cell lymphoma, intrathoracic lymph nodes – SOAP Notes & Clinical Use
ICD-10 Code C83.32 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of patients with Diffuse large B-cell lymphoma affecting intrathoracic lymph nodes. This code is relevant in both acute and chronic care settings, facilitating accurate medical records and billing.
What Does ICD-10 Code C83.32 for Diffuse large B-cell lymphoma, intrathoracic lymph nodes Mean in SOAP Notes?
In SOAP notes, ICD-10 Code C83.32 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Diffuse large B-cell lymphoma. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
Treatment Options for ICD-10 Code C83.32 – Diffuse large B-cell lymphoma, intrathoracic lymph nodes
The management of Diffuse large B-cell lymphoma affecting intrathoracic lymph nodes often necessitates urgent intervention due to its aggressive nature.
Antibiotic Therapy:
- Not applicable as DLBCL is not an infectious condition; treatment focuses on chemotherapy and immunotherapy.
Supportive Care:
- Symptom management including pain control and management of side effects from chemotherapy.
- Nutritional support to maintain strength during treatment.
- Psychosocial support for patients and families.
Infection Control:
- Standard precautions to prevent infections during immunosuppressive therapy.
- Monitoring for febrile neutropenia and other complications.
How to Document Symptoms of Diffuse large B-cell lymphoma, intrathoracic lymph nodes (ICD-10 C83.32) in SOAP Notes
Subjective:
- Patient reports persistent cough and shortness of breath.
- History of unexplained weight loss and night sweats.
- Complaints of chest discomfort and fatigue.
Objective:
- Physical examination reveals enlarged supraclavicular and mediastinal lymph nodes.
- Chest X-ray shows mediastinal mass.
- Laboratory tests indicate elevated lactate dehydrogenase (LDH) levels.
Secure, compliant, and built for trust
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn more
SOAP Note Guidelines for Diagnosing Diffuse large B-cell lymphoma, intrathoracic lymph nodes (ICD-10 Code C83.32)
Assessment:
- Diagnosis: Diffuse large B-cell lymphoma, intrathoracic lymph nodes, classified as aggressive.
- ICD-10 Code: C83.32.
- Contributing factors include advanced age and possible immunocompromised state.
Plan:
- Initiate chemotherapy regimen (e.g., R-CHOP protocol).
- Provide education on treatment side effects and management strategies.
- Schedule follow-up appointments for monitoring response to therapy.
Treatment & Plan Section for ICD-10 Code C83.32 – Diffuse large B-cell lymphoma, intrathoracic lymph nodes
- First-line treatment typically includes combination chemotherapy (e.g., R-CHOP).
- Consider radiation therapy for localized disease after chemotherapy.
- Regular monitoring through imaging and laboratory tests to assess treatment response.
- Patient education on recognizing symptoms of complications and when to seek care.
Using ICD-10 Code C83.32 for Diffuse large B-cell lymphoma, intrathoracic lymph nodes in Billing & SOAP Note Compliance
- Ensure accurate documentation of symptoms and clinical findings under Subjective (S) and Objective (O).
- Utilize C83.32 in billing to reflect the diagnosis and support treatment claims.
- Align treatment plans with clinical guidelines to justify billing and reimbursement.
- Include relevant CPT codes that correspond to the services provided.
Related ICD-10 Codes Often Used with Diffuse large B-cell lymphoma, intrathoracic lymph nodes
- C83.30 – Diffuse large B-cell lymphoma, unspecified site
- C83.31 – Diffuse large B-cell lymphoma, lymph nodes of head, face, and neck
- C83.33 – Diffuse large B-cell lymphoma, lymph nodes of axilla and upper limb
- C83.34 – Diffuse large B-cell lymphoma, lymph nodes of abdomen
ICD-10 Code C83.32 in Medical Billing and Insurance for Diffuse large B-cell lymphoma, intrathoracic lymph nodes
ICD-10 Code C83.32 is critical in medical billing, particularly in hospital, emergency room, or oncology settings.
Billing Notes:
- Document all relevant clinical findings and treatment plans to support the use of C83.32.
- Ensure that the diagnosis is clearly linked to the services billed.
- Use C83.32 in conjunction with appropriate CPT codes for chemotherapy and follow-up care.
Common CPT Pairings:
| CPT Code | Description |
|---|---|
| 96413 | Chemotherapy administration, intravenous, push, single or initial substance. |
| 99214 | Established patient office visit, moderate complexity. |
| 77014 | Ultrasound guidance for needle placement. |
Frequently Asked Questions
Common Questions About Using ICD-10 Code C83.32 for Diffuse large B-cell lymphoma, intrathoracic lymph nodes
What are the common symptoms of Diffuse large B-cell lymphoma?
Common symptoms include swollen lymph nodes, fever, night sweats, unexplained weight loss, and fatigue. Patients may also experience respiratory symptoms if lymph nodes in the thorax are affected.
How is Diffuse large B-cell lymphoma diagnosed?
Diagnosis typically involves a combination of physical examination, imaging studies (like CT scans), and biopsy of affected lymph nodes to confirm the presence of malignant B-cells.
What is the treatment for Diffuse large B-cell lymphoma?
Treatment usually involves chemotherapy, often with a regimen known as R-CHOP, and may include radiation therapy depending on the stage and location of the disease.
Is Diffuse large B-cell lymphoma curable?
Diffuse large B-cell lymphoma can be curable, especially if diagnosed early and treated promptly. The prognosis varies based on several factors, including the patient's overall health and response to treatment.
